Health Care & Hospital Law,
Civil Litigation
Oct. 4, 2021
$52B opioid trial ends with tense attorney-judge exchange
“It took five times for the court to finally get an answer to its question, ‘Is there any evidence that any medically inappropriate prescriptions were written, based upon any statements made by any of the defendants?’” Newport Beach defense attorney Michael Yoder of O’Melveny & Myers LLP said during his closing argument Friday.
Closing arguments in a $52 billion opioid bench trial came to a fiery end Friday in Orange County after lawyers representing drug manufacturers pounced on the fact that the judge had sharply questioned the state's counsel about evidence during her closing argument the day before.
In the final days of the first government-initiated action in the nation seeking to hold opioid manufacturers accountable for a role in creating the opioid epidem...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In
Enewsletter Sign-up
Related Content
Health Care & Hospital Law, Civil Litigation
No evidence drugmakers falsely marketed opioids, judge rules
By Blaise Scemama
Government, Civil Litigation, Bankruptcy
California to appeal Purdue Pharma settlement
By Blaise Scemama
Civil Litigation, Bankruptcy
Purdue portends a change of bankruptcy venue laws
By Brian Davidoff
Health Care & Hospital Law, Civil Litigation
Some plaintiffs are asking if $26B opioid settlement is enough
By Blaise Scemama
Health Care & Hospital Law, Civil Litigation
Challenge to pharmacy’s opioid control is dismissed
By Winston Cho
Health Care & Hospital Law
Body brokers unlawfully profit off of vulnerable members of society
By Doug Rochen
Torts
People v. ConAgra Grocery Products Co.
Where record shows defendants ceased promoting indoor residential use of lead paint after 1950, evidence insufficient to require defendants to remediate homes built after that point and c...